💊 Lupin gets an FDA nod, and an FDA rebuke; Bharat Biotech plans a Mexican sojourn

Apr 19, 2022

∙ Paid

It’s been slow days this week, particularly on the life sciences news front. Maybe it’s the heat. Maybe a certain cosmetic brand.

In today’s Kable: the WHO counters India; Lupin gets a green light from the US FDA and also a red signal; Big Brother gets big bucks for Blue Spark; ASHRAE wants your comments.

💊 Lupin gets an FDA nod, and an FDA rebuke; Bharat Biotech plans a Mexican sojourn

This post is for paid subscribers